Last reviewed · How we verify

Hymenoptera venom

University of Rostock · FDA-approved active Biologic ✓ Verified May 2026 Quality 2/100

Hymenoptera venom is a Biologic drug developed by University of Rostock. It is currently FDA-approved.

Hymenoptera venom is used to treat allergies, including Hymenoptera venom allergy, Birch Pollen Allergy, Grass Pollen Allergy, House Dust Mite Allergy, and Cat Allergy. The venom works by interacting with proteins in the body, as it is classified as a protein-based modality.

At a glance

Generic nameHymenoptera venom
SponsorUniversity of Rostock
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Hymenoptera venom

What is Hymenoptera venom?

Hymenoptera venom is a Biologic drug developed by University of Rostock.

Who makes Hymenoptera venom?

Hymenoptera venom is developed and marketed by University of Rostock (see full University of Rostock pipeline at /company/university-of-rostock).

What development phase is Hymenoptera venom in?

Hymenoptera venom is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing